Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HAL Investments is the Dutch investment subsidiary of HAL Holding and operates as a long-term investment company rather than a drug developer, pharmaceutical manufacturer, or healthcare operating company. It invests its own capital in listed and private businesses across multiple sectors, including selective exposure to healthcare-related portfolio companies such as medical aids and healthcare software/services. The firm focuses on acquiring significant stakes in companies with durable market positions and supports growth through long-term capital, M&A, and business development. Because HAL Investments is an investment holding platform, it does not itself maintain a therapeutic pipeline, clinical programs, or modality-specific R&D platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HAL Investments.